Search results
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 4 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Kansas attorney general sues Pfizer over marketing of COVID-19 vaccine
The Day· 3 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 3 days agoIn a lawsuit filed on Monday, the U.S. state alleges Pfizer made false statements about the safety...
Kansas AG sues Pfizer over 'misleading' COVID-19 vaccine claims
FOX 23 Maine· 4 days agoKansas Attorney General Kris Kobach announced Monday he is suing pharmaceutical giant Pfizer for...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
The Topeka Capital-Journal via Yahoo News· 4 days agoFollowing Texas' lead Texas Attorney General Ken Paxton is pursuing a similar lawsuit against Pfizer...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka via Yahoo News· 4 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Kansas AG Kris Kobach suing Pfizer for ‘misleading Kansans on COVID vaccine’
KWCH· 4 days agoKansas Attorney General Kris Kobach announced that he’s suing Pfizer “for misleading claims it made...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 3 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine, becoming the second ...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 3 days agoImage Source: Getty Images. Here is a head-to-head comparison of these popular healthcare dividend...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 3 days agoPfizer Currently Dominates Market FDA approval of Merck’s new pneumococcal vaccine, Capvaxive, tees...